APA (7th ed.) Citation

AY, A., SA, A., E, B., HO, A., Z, A., Y, B., . . . AM, H. (2025). Predictive and Prognostic Significance of Patient-Reported Outcomes for Survival and Adverse Events in Daratumumab-Treated Multiple Myeloma. European journal of haematology, 114(6), 1020. https://doi.org/10.1111/ejh.14410

Chicago Style (17th ed.) Citation

AY, Abuhelwa, et al. "Predictive and Prognostic Significance of Patient-Reported Outcomes for Survival and Adverse Events in Daratumumab-Treated Multiple Myeloma." European Journal of Haematology 114, no. 6 (2025): 1020. https://doi.org/10.1111/ejh.14410.

MLA (9th ed.) Citation

AY, Abuhelwa, et al. "Predictive and Prognostic Significance of Patient-Reported Outcomes for Survival and Adverse Events in Daratumumab-Treated Multiple Myeloma." European Journal of Haematology, vol. 114, no. 6, 2025, p. 1020, https://doi.org/10.1111/ejh.14410.